Stallergenes Greer Group

A leader in allergen immunotherapy

With more than a century of expertise in allergies and allergen immunotherapy (AIT), Stallergenes Greer is a leader in its field.

Stallergenes Greer, a fully integrated global biopharmaceutical company, specialises in the diagnosis and treatment of allergies through the research, development and commercialisation of AIT products and services for respiratory and food allergies.

The company’s product portfolio, which covers a broad range of administration modes, offers healthcare professionals innovative solutions to improve life for people with allergies.

About allergen immunotherapy

Allergen immunotherapy (AIT) is a specific treatment designed to treat the underlying cause of a given allergic disease. Treatment consists of exposing a person, under close medical supervision, to strictly measured increments of the allergen. Treatment aims to desensitise the specific immune responses that lead to the allergic reaction leading to increased allergen-specific immune tolerance and a reduction in related symptoms¹. 

_{¹ Global Atlas of Allergy, EAACI 2014}